Free Webinar

Jan 30, 2pm GMT / 9am ET

Accelerating Medical Affairs:
Gen AI trends shaping evidence, engagement & impact in 2026.

Join us Jan 30 to learn what Medical Affairs leaders learned about GenAI in 2025, and what they're funding in 2026!

Our expert speakers will share real-world examples of how MA teams are using GenAI to accelerate literature and evidence synthesis, support scientific content development, and improve stakeholder engagement, with the right human oversight.

What you’ll learn:
1) The Standard for 2026: Understand 2025 Gen AI trends, what’s worked and where experts are investing budget and resources in 2026.
2) The Anatomy of a Product Agent: A technical look at how to use internal agents to synthesize data across labels, trial protocols, FAQs, and publications for instant, accurate insights.
3) What’s ready for Gen AI: A practical view of which Medical Affairs processes can be augmented today - and which still require human-led control.

Your Presenters

Eleanor Barr

Senior AI Consultant, Syneos Health

With an academic background in machine learning, which sparked her passion for innovation at the intersection of technology and healthcare, Eleanor combines her experience in client service for medical communications and advertising with deep technical knowledge. Currently, Eleanor is a Senior AI Consultant at Syneos Health, where she develops and implements Generative AI solutions for global clients and internal products.

Alex Brock

MD Digital and Omnichannel, Syneos Health

Alex leads omnichannel and digital for communications across Syneos Health in Europe, and runs the central omnichannel team based in our London HQ. He has worked at Syneos for 10+ years, overseeing the evolution of digital insight, strategy and optimisation across the business. This has involved a range of approaches including omnichannel planning, patient journey mapping, social media listening and implementation, digital measurement / analytics and digital campaign management. Alex pioneered our internal Generative AI education and delivered our first client project with large language models six months before ChatGPT launched. He sits on our broader Syneos Health AI Council and leads our current Generative AI engagements.

Robin Jones

Digital Brand Manager, AstraZeneca

Robin has dedicated over a decade to transforming how healthcare professionals engage with emerging technologies. As a leader in generative AI integration, Robin has spearheaded AstraZeneca's UK initiatives, focusing on tools like ChatGPT to enhance clinical and commercial strategies. Since 2023, Robin has been instrumental in developing applications of Large Language Models in health technology assessments and marketing, ensuring compliance with industry standards. Robin’s current work includes designing workshops to demonstrate AI's potential in campaign planning and decision-making, blending technical expertise with practical business insights.

aCCESS THE FREE WEBINAR